Andrew Weinberg
![Andrew Weinberg Andrew Weinberg](https://til-therapies.com/wp-content/uploads/sites/262/2024/05/Andrew-Weinberg-Speaker-150x150.png)
Company: AgonOx
Job title: President & Chief Scientific Officer
Seminars:
Unveiling Novel Approaches to Expanding Tumor- Reactive T-Cells & Reducing Bystander T-Cells 2:30 pm
Sorting CD8 TIL for CD39 and CD103 prior to expansion enhances for tumor reactivity This selected expanded TIL has clinical activity in late-stage cancer patientsRead more
day: Conference Day One - Track B - PM